Avanos Medical Stock Alpha and Beta Analysis

AVNS Stock  USD 19.10  0.07  0.37%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Avanos Medical. It also helps investors analyze the systematic and unsystematic risks associated with investing in Avanos Medical over a specified time horizon. Remember, high Avanos Medical's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Avanos Medical's market risk premium analysis include:
Beta
1.64
Alpha
(0.50)
Risk
2.89
Sharpe Ratio
(0.11)
Expected Return
(0.32)
Please note that although Avanos Medical alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Avanos Medical did 0.50  worse than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Avanos Medical stock's relative risk over its benchmark. Avanos Medical has a beta of 1.64  . As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Avanos Medical will likely underperform. Book Value Per Share is likely to gain to 32.46 in 2024. Tangible Book Value Per Share is likely to gain to 5.47 in 2024.

Enterprise Value

2.29 Billion

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Avanos Medical Backtesting, Avanos Medical Valuation, Avanos Medical Correlation, Avanos Medical Hype Analysis, Avanos Medical Volatility, Avanos Medical History and analyze Avanos Medical Performance.
For more information on how to buy Avanos Stock please use our How to Invest in Avanos Medical guide.

Avanos Medical Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Avanos Medical market risk premium is the additional return an investor will receive from holding Avanos Medical long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Avanos Medical. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Avanos Medical's performance over market.
α-0.5   β1.64

Avanos Medical expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Avanos Medical's Buy-and-hold return. Our buy-and-hold chart shows how Avanos Medical performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Avanos Medical Market Price Analysis

Market price analysis indicators help investors to evaluate how Avanos Medical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Avanos Medical shares will generate the highest return on investment. By understating and applying Avanos Medical stock market price indicators, traders can identify Avanos Medical position entry and exit signals to maximize returns.

Avanos Medical Return and Market Media

The median price of Avanos Medical for the period between Thu, Sep 5, 2024 and Wed, Dec 4, 2024 is 22.62 with a coefficient of variation of 9.85. The daily time series for the period is distributed with a sample standard deviation of 2.15, arithmetic mean of 21.83, and mean deviation of 1.92. The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
       Timeline  
1
Avanos Medical Upgraded to Strong Buy What Does It Mean for the Stock
10/17/2024
2
West Pharmaceutical Stock Gains on Q3 Earnings Beat Raised Guidance
10/24/2024
3
Insider Trading
10/28/2024
4
Acquisition by Michael Greiner of 44189 shares of Avanos Medical subject to Rule 16b-3
10/29/2024
5
Avanos Medical Inc Reports Q3 2024 Earnings EPS at 0.12, Revenue at 170. ...
10/30/2024
6
Q3 2024 Avanos Medical Inc Earnings Call Transcript
10/31/2024
7
Avanos Medical announces share buyback
11/05/2024
8
Disposition of 2231 shares by Michael Greiner of Avanos Medical at 19.13 subject to Rule 16b-3
11/08/2024
9
Synaptrix announces tranche update - Marketscreener.com
11/21/2024
10
Acquisition by Joseph Woody of 80933 shares of Avanos Medical subject to Rule 16b-3
11/22/2024
11
Acquisition by John Byrnes of 7008 shares of Avanos Medical subject to Rule 16b-3
11/29/2024

About Avanos Medical Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Avanos or other stocks. Alpha measures the amount that position in Avanos Medical has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2023 2024 (projected)
PTB Ratio0.851.45
Dividend Yield0.290.26

Avanos Medical Upcoming Company Events

As portrayed in its financial statements, the presentation of Avanos Medical's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Avanos Medical's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Avanos Medical's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Avanos Medical. Please utilize our Beneish M Score to check the likelihood of Avanos Medical's management manipulating its earnings.
20th of February 2024
Upcoming Quarterly Report
View
1st of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
20th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Build Portfolio with Avanos Medical

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Additional Tools for Avanos Stock Analysis

When running Avanos Medical's price analysis, check to measure Avanos Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avanos Medical is operating at the current time. Most of Avanos Medical's value examination focuses on studying past and present price action to predict the probability of Avanos Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avanos Medical's price. Additionally, you may evaluate how the addition of Avanos Medical to your portfolios can decrease your overall portfolio volatility.